GLP-1 receptor agonists may be appropriate second-line agents after metformin or even first-line in patients with established cardiovascular disease, chronic kidney disease, or when weight management is a priority
The FDA has approved several GLP-1 receptor agonists for type 2 diabetes management and, in some cases, chronic weight management
The GLP-1 drug patches containing semaglutide are still in their experimental stage
Side Effects of GLP-1 Patches Since these patches dont contain actual GLP-1 medication, you wont experience the typical side effects associated with prescription GLP-1 drugs like nausea or vomiting
We pack more into each patch than most brands put in a bottle, and our smooth peel-clear backing makes application effortless every single time
Other ingredients that might be present include caffeine, green tea extract, etc